Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcomeYung-Yeh Su,Yih-Jyh Lin,Chin-Fu Hsiao,Da-Liang Ou,San-Chi Chen,Hung-Wei Wang,Jing-Houng Wang,Yao-Ming Wu,Wei-Chen Lee, Shu-Cheng Chou,Ching-Liang Ho,Chang-Fang Chiu,Li-Tzong Chen, Yen-Shan Shen,Ann-Lii Cheng,Chiun HsuANNALS OF ONCOLOGY(2023)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要